Kukje Pharma Co Ltd (002720) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.052x

Based on the latest financial reports, Kukje Pharma Co Ltd (002720) has a cash flow conversion efficiency ratio of 0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.99 Billion ≈ $3.38 Million USD) by net assets (₩95.32 Billion ≈ $64.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Kukje Pharma Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Kukje Pharma Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Kukje Pharma Co Ltd (002720) total liabilities for a breakdown of total debt and financial obligations.

Kukje Pharma Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kukje Pharma Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Everest Industries Limited NSE:EVERESTIND	-0.029x
Redtone International Bhd KLSE:0032	-0.013x
VELA TECHNOL.PLC LS-0001 F:IBNN	N/A
Amoeba SA PA:ALMIB	0.187x
Catalyst Bancorp Inc NASDAQ:CLST	0.011x
Urja Global Limited NSE:URJA	-0.086x
Wooree Bio Co.Ltd KQ:082850	0.057x
Linc Limited NSE:LINC	0.108x

Annual Cash Flow Conversion Efficiency for Kukje Pharma Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Kukje Pharma Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Kukje Pharma Co Ltd (002720) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩89.55 Billion ≈ $60.69 Million	₩3.94 Billion ≈ $2.67 Million	0.044x	+4.54%
2023-12-31	₩84.95 Billion ≈ $57.57 Million	₩3.58 Billion ≈ $2.42 Million	0.042x	-52.06%
2022-12-31	₩74.08 Billion ≈ $50.20 Million	₩6.50 Billion ≈ $4.41 Million	0.088x	-37.26%
2021-12-31	₩68.59 Billion ≈ $46.48 Million	₩9.60 Billion ≈ $6.50 Million	0.140x	+93.42%
2020-12-31	₩70.50 Billion ≈ $47.78 Million	₩5.10 Billion ≈ $3.46 Million	0.072x	+22.36%
2019-12-31	₩60.95 Billion ≈ $41.31 Million	₩3.60 Billion ≈ $2.44 Million	0.059x	-69.34%
2018-12-31	₩68.70 Billion ≈ $46.56 Million	₩13.25 Billion ≈ $8.98 Million	0.193x	+1562.80%
2017-12-31	₩67.78 Billion ≈ $45.93 Million	₩786.10 Million ≈ $532.73K	0.012x	-95.14%
2016-12-31	₩67.52 Billion ≈ $45.76 Million	₩16.10 Billion ≈ $10.91 Million	0.238x	+421.30%
2015-12-31	₩68.46 Billion ≈ $46.39 Million	₩-5.08 Billion ≈ $-3.44 Million	-0.074x	-6075.28%
2014-12-31	₩50.85 Billion ≈ $34.46 Million	₩-61.11 Million ≈ $-41.41K	-0.001x	+98.47%
2013-12-31	₩58.33 Billion ≈ $39.53 Million	₩-4.60 Billion ≈ $-3.11 Million	-0.079x	-376.04%
2012-12-31	₩55.35 Billion ≈ $37.51 Million	₩1.58 Billion ≈ $1.07 Million	0.029x	-87.72%
2011-12-31	₩74.79 Billion ≈ $50.69 Million	₩17.39 Billion ≈ $11.78 Million	0.232x	--

About Kukje Pharma Co Ltd

KO:002720 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$65.00 Million

₩95.91 Billion KRW

Market Cap Rank

#20870 Global

#1279 in Korea

Share Price

₩4710.00

Change (1 day)

-1.46%

52-Week Range

₩4100.00 - ₩5230.00

All Time High

₩12612.03